The Union Health Ministry of India has approved Corbevax as a heterologous COVID-19 booster dose under emergency use authorization for individuals aged 18 years.
China has agreed to finance a feasibility study for a cross-border railway with Nepal under the trans-Himalayan multi-dimensional connectivity network.